Prelude Capital Management, LLC Chroma Dex Corp. Transaction History
Prelude Capital Management, LLC
- $1.5 Billion
- Q4 2024
A detailed history of Prelude Capital Management, LLC transactions in Chroma Dex Corp. stock. As of the latest transaction made, Prelude Capital Management, LLC holds 15,474 shares of CDXC stock, worth $83,869. This represents 0.01% of its overall portfolio holdings.
Number of Shares
15,474Holding current value
$83,869% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding CDXC
# of Institutions
129Shares Held
21.9MCall Options Held
203KPut Options Held
23.9K-
Vanguard Group Inc Valley Forge, PA3.39MShares$18.4 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.12MShares$16.9 Million0.0% of portfolio
-
Tieton Capital Management, LLC Yakima, WA2.59MShares$14 Million5.52% of portfolio
-
Iconiq Capital, LLC San Francisco, CA1.3MShares$7.03 Million0.14% of portfolio
-
Geode Capital Management, LLC Boston, MA1.15MShares$6.26 Million0.0% of portfolio
About ChromaDex Corp.
- Ticker CDXC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 68,350,896
- Market Cap $370M
- Description
- ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...